Physician profile
Matthew L Lyons
NPI 1144429069
$1,269.25
in general payments reported to CMS, 2019-2025
8 companies · $742 in 2025
The $742 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $24.58 · 2021: $19.17 · 2022: $34.06 · 2023: $327 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639 · Travel and Lodging: $395 · Gift: $34.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.08 |
| Travel and Lodging | $394.52 |
| Gift | $34.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $721.63 | 2025 | Inset System |
| Linvatec Corporation | $282.92 | 2022-2023 | Biobrace 23mm |
| Zimmer Biomet Holdings, INC. | $130.42 | 2019-2021 | |
| Stryker Corporation | $57.05 | 2023 | Simpliciti, Tornier Perform Reversed Augmented Glenoid, Tornier Perform Reversed Glenoid |
| Zyla Life Sciences, INC. | $24.58 | 2020 | |
| Endo Pharmaceuticals INC. | $20.86 | 2023 | Xiaflex |
| Invictus Surgical Incorporated | $20.13 | 2025 | |
| Axogen | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.